title: Immunology and microbiology devices; reclassification of the herpes simplex virus serological assay device. Final rule.
abstract: The Food and Drug Administration (FDA) is amending the special controls for the herpes simplex virus (HSV) serological assay device type, which is classified as class II (special controls). These device types are devices that consist of antigens and antisera used in various serological tests to identify antibodies to herpes simplex virus in serum, and the devices that consist of herpes simplex virus antisera conjugated with a fluorescent dye (immunofluorescent assays) used to identify herpes simplex virus directly from clinical specimens or tissue culture isolates derived from clinical specimens.
mesh_terms: D000914:Antibodies, Viral / Q000097:blood; D018795:Device Approval / Q000331:legislation & jurisprudence; D004869:Equipment Safety / Q000145:classification*; D006801:Humans; D007118:Immunoassay / Q000145:classification*; D012698:Serologic Tests / Q000145:classification*; D018139:Simplexvirus; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000914:Antibodies, Viral